What makes this stock unique in my portfolio is that the world is desperate for a product that does what we know ours does; kill things that are resistant to all other known treatments and with efficacy that doesn't diminish over time or with frequency of use. I'm confident that funding will be thrown at us from all directions as the story plays out and risk is reduced. Melrose (ex-Johnson & Johnson, with around 300B MC) is no amateur in this field. I believe his knowledge, experience and connections will see this to fruition and attract the capital required to get there.
What makes this stock unique in my portfolio is that the world...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $118.1M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 46.5¢ | $2.131K | 4.582K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1263 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 11173 | 5 |
View Market Depth
| Last trade - 12.38pm 04/12/2024 (20 minute delay) ? |
| RCE (ASX) Chart |
